|
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine |
Kate's Cause |
|
Multivalent Nanomedicine to Treat High-Risk Pediatric Solid Tumors |
Children's Hospital of Philadelphia |
Flashes of Hope |
|
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida |
Tap Cancer Out, Layla’s Legacy Foundation |
|
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida |
Tap Cancer Out, Layla’s Legacy Foundation |
|
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope, Tap Cancer Out |
|
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope, Tap Cancer Out |
|
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University |
Tap Cancer Out |
|
Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
The Regents of the University of Michigan |
Flashes of Hope, McKenna Claire Foundation |
|
Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
The Regents of the University of Michigan |
Flashes of Hope, McKenna Claire Foundation |
|
Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia |
St. Jude Children's Research Hospital |
Tap Cancer Out |
